Biota Pharmaceuticals, Inc.

34% Drop in Biota Pharmaceutical, Inc.’s Stock Price: Law Firm Investigates on Behalf of Shareholders

Robbins Arroyo LLP is investigating potential violations of federal securities laws on behalf of investors of Biota Pharmaceutical, Inc. (NYSE: BOTA). Biota Pharmaceuticals is a biopharmaceutical company that focuses on the discovery and development of anti-infective products.

Biota Pharmaceuticals Shares Fall on Termination of Laninamivir Octanoate Contract

Shares of Biota Pharmaceuticals fell 34%, to close at $3.68 on April 29, 2014, following an announcement by the company that the U.S. Department of Health and Human Services office of the Assistant Secretary for Preparedness and Response and Biomedical Advanced Research and Development Authority (BARDA) issued a Stop-Work Order “notifying the Company to discontinue work on a number of activities under [its] contract.” The Stop-Work Order is contingent upon the outcome of an In Process Review of the Biota’s contract for the development of laninamivir octanoate. The BARDA contract provides up to $231 million in financial support for the development of laninamivir octanoate for the treatment of influenza A and B in the United States.

Biota Pharmaceutical Shareholders Are Encouraged to Contact Shareholder Rights Law Firm Robbins Arroyo LLP

If you invested in Biota Pharmaceuticals and would like to discuss your shareholder rights, please contact attorney Darnell R. Donahue at (800) 350-6003, or you can complete the form below and we will contact you directly.

 

Shareholder Information

Items marked with an asterisk (*) are required information.

First Name * Last Name *
Address City State/Province *
ZIP/Postal Code Country/Region Phone *
E-mail * Confirm: E-mail *

Shares Purchased:
Number of Shares: Buy Date : Price Per Share:
example: 125 example: MM/DD/YYYY example: 30.00
transaction:
transaction:
transaction:
transaction:
transaction:
If you have additional transactions or comments, please input the information below:

Shares Sold:
Number of Shares: Buy Date : Price Per Share:
example: 125 example: MM/DD/YYYY example: 30.00
transaction:
transaction:
transaction:
transaction:
transaction:
If you have additional transactions or comments, please input the information below:

Please Note: Neither the submission to nor the receipt of information by Robbins Arroyo LLP or one of its attorneys through this website constitutes an agreement by our firm to represent the individual and does not create an attorney-client relationship. Please do not send confidential or sensitive information through this website. This information should be communicated through a direct contact with an individual at the firm.

* I have read the disclaimer information
+=

    Send This Post

    Tags: